Model-based rational design of an oncolytic virus with improved therapeutic potential
Nature Communications2013Vol. 4(1), pp. 1974–1974
Citations Over TimeTop 10% of 2013 papers
Fabrice Le Bœuf, Cory Batenchuk, Markus Vähä‐Koskela, Sophie Breton, Dominic G. Roy, Chantal G. Lemay, Julie A. Cox, Hesham Abdelbary, Theresa Falls, Girija Waghray, Harold Atkins, David F. Stojdl, Jean‐Simon Diallo, Mads Kærn, John C. Bell
Related Papers
- → Oncolytic Virotherapy as Promising Immunotherapy Against Cancer: Mechanisms of Resistance to Oncolytic Viruses(2021)31 cited
- → Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model(2019)26 cited
- → Treatment of Metastatic Neuroblastoma with Mesenchymal Stem Cell‐Based Oncolytic Virotherapy(2013)
- → Mesenchymal stem cells as carrier cells to enable effective intratumoral delivery of oncolytic virus for oncolytic virotherapy: a systematic review(2022)
- → Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer(2023)